Skip to main content
FEMASYS INC logo

FEMASYS INC — Investor Relations & Filings

Ticker · FEMY ISIN · US31447E1055 US Manufacturing
Open in API
Filings indexed 297 across all filing types
Latest filing 2026-06-05 Regulatory Filings
Country US United States of America
Listing US FEMY

About FEMASYS INC

https://www.femasys.com/

Femasys Inc. is a biomedical company that develops and commercializes therapeutic and diagnostic solutions focused on women's reproductive health. The company's mission is to provide innovative, non-surgical advancements for underserved areas in women's healthcare. Its key products include FemaSeed®, an FDA-cleared infertility treatment for intrauterine directional insemination that delivers sperm directly to the fallopian tube, and FemBloc®, a non-surgical system for permanent birth control. Femasys aims to offer more accessible and less invasive alternatives to traditional medical procedures in fertility and contraception.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2026-06-05 English
8-K
Share Issue/Capital Change Classification · 95% confidence The document is a Form 8-K current report filed under the Securities Exchange Act of 1934, Item 7.01 Regulation FD Disclosure, announcing a 1-for-20 reverse stock split of common shares. This is an announcement of a capital structure change (stock split). According to the definitions, announcements regarding stock splits or other capital changes fall under Share Issue/Capital Change (Code: SHA).
2026-06-04 English
8-K - FEMASYS INC (0001339005) (Filer)
Investor Presentation Classification · 92% confidence The document is a Form 8-K “Current Report” filed under Item 7.01 (Regulation FD Disclosure), noting that the company has posted and attached an updated slide presentation (Exhibit 99.1) for use with investors, analysts, and other parties. This is not the company’s financial statements, earnings release or a mere press release announcement—it is an actual investor slide deck being furnished as an exhibit. According to the filing definitions, this corresponds to an Investor Presentation (IP).
2026-05-13 English
8-K - FEMASYS INC (0001339005) (Filer)
Regulatory Filings Classification · 78% confidence The document is a Form 8-K “Current Report” filed with the SEC under the Exchange Act to furnish a press release with quarterly financial results. It contains no substantive financial statements itself but rather attaches an Exhibit (press release). There is no specific category for an 8-K, so under the fallback “general regulatory filings” it should be classified as RNS.
2026-05-08 English
DEF 14A - FEMASYS INC (0001339005) (Filer)
Proxy Solicitation & Information Statement
2026-04-30 English
DEF 14A - FEMASYS INC (0001339005) (Filer)
Proxy Solicitation & Information Statement
2026-04-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.